RESEARCH ARTICLE
Azithromycin and Reported Increased Risk of Cardiovascular Death
Kelly N. Koenig*, Craig G. Burkhart
Article Information
Identifiers and Pagination:
Year: 2012Volume: 6
First Page: 55
Last Page: 56
Publisher ID: TODJ-6-55
DOI: 10.2174/1874372201206010055
Article History:
Received Date: 15/10/2012Revision Received Date: 11/11/2012
Acceptance Date: 11/11/2012
Electronic publication date: 11/12/2012
Collection year: 2012
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Contrary to previous reports, azithromycin has now been associated with arrythmias and sudden cardiac deaths. There is a need for careful consideration of these risk factors with this drug especially when prescribing for the elderly. A more thorough screening of cardiovascular risk prior to starting azithromycin may also be warranted.